These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8222340)

  • 1. Effect of nicorandil on post-ischaemic contractile dysfunction in the heart: roles of its ATP-sensitive K+ channel opening property and nitrate property.
    Iwamoto T; Miura T; Urabe K; Itoya M; Shimamoto K; Iimura O
    Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):595-602. PubMed ID: 8222340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia.
    Sugimoto S; Iwashiro K; Monti F; Dawodu AA; Schiariti M; Puddu PE
    Int J Cardiol; 1995 Jan; 48(1):11-25. PubMed ID: 7744533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
    Warltier DC; Auchampach JA; Gross GJ
    J Card Surg; 1993 Mar; 8(2 Suppl):279-83. PubMed ID: 8461517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
    Auchampach JA; Cavero I; Gross GJ
    J Cardiovasc Pharmacol; 1992; 20(5):765-71. PubMed ID: 1280739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective mitochondrial KATP channel activation by nicorandil and 3-pyridyl pinacidil results in antiarrhythmic effect in an anesthetized rabbit model of myocardial ischemia/reperfusion.
    Das B; Sarkar C
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):97-110. PubMed ID: 12731455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glibenclamide and nicorandil in post-ischaemic contractile dysfunction of perfused hearts in normotensive and spontaneously hypertensive rats.
    Nakagawa C; Asayama J; Tatsumi T; Matoba S; Kobara M; Tanaka T; Ohta B; Kawahara A; Tsuruyama K; Katamura M; Nakagawa M
    J Hypertens; 1996 Jul; 14(7):921-6. PubMed ID: 8818933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on myocardial stunning in xanthine-oxidase deficient hearts: pre-treatment vs. post-ischemic treatment.
    Adachi T; Miura T; Suzuki K; Iimura O
    Basic Res Cardiol; 1994; 89(1):16-28. PubMed ID: 8010931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: potentiation of ischaemic preconditioning via KATP channels.
    Nakae I; Takaoka A; Mitsunami K; Yabe T; Ito M; Masayuki ; Takahashi ; Matsumoto T; Omura T; Yokohama H; Kinoshita M
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):810-7. PubMed ID: 11022974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of concomitant administration of isoflurane and nicorandil.
    Piriou V; Ross S; Pigott D; Evans R; Foex P
    Br J Anaesth; 1997 Jul; 79(1):68-77. PubMed ID: 9301392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits.
    Ohno Y; Minatoguchi S; Uno Y; Kariya T; Arai M; Yamashita K; Fujiwara T; Fujiwara H
    Int J Cardiol; 1997 Dec; 62(3):181-90. PubMed ID: 9476676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ATP-dependent K+ channels enhances myocardial protection due to cold high potassium cardioplegia: a force-frequency relationship study.
    Sugimoto S; Puddu PE; Monti F; Dawodu AA; del Monte F; Schiariti M; Campa PP; Marino B
    J Mol Cell Cardiol; 1995 Sep; 27(9):1867-81. PubMed ID: 8523448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
    Yao Z; Gross GJ
    Circulation; 1993 Jul; 88(1):235-44. PubMed ID: 8319338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP gated potassium channels in acute myocardial hibernation and reperfusion.
    Offstad J; Kirkebøen KA; Ilebekk A; Downing SE
    Cardiovasc Res; 1994 Jun; 28(6):872-80. PubMed ID: 7923294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischaemic, reperfused porcine hearts.
    Klein HH; Pich S; Lindert-Heimberg S; Schade-Brittinger C; Maisch B; Nebendahl K
    Eur Heart J; 1995 May; 16(5):603-9. PubMed ID: 7588890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts.
    Mitani A; Kinoshita K; Fukamachi K; Sakamoto M; Kurisu K; Tsuruhara Y; Fukumura F; Nakashima A; Tokunaga K
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1864-71. PubMed ID: 1836311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.
    Imagawa J; Baxter GF; Yellon DM
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):74-9. PubMed ID: 9456280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.